📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review. (2017)

First Author: Mendoza-Pinto C

Attributed to: MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.semarthrit.2017.01.009

PubMed Identifier: 28325471

Publication URI: http://europepmc.org/abstract/MED/28325471

Type: Journal Article/Review

Volume: 47

Parent Publication: Seminars in arthritis and rheumatism

Issue: 1

ISSN: 0049-0172